Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Paolo A. Ascierto, M. Nyhuus Bendix Rasch et al.|European Journal of Cancer|2025Cited by 7
Combination or sequence of vemurafenib, cobimetinib, and atezolizumab in high-risk, resectable melanoma (NEO-TIM): Primary results.Paolo A. Ascierto, Vanna Chiarion‐Sileni, Pietro Quaglino et al.|Journal of Clinical Oncology|2024Cited by 2